Clinical Trial Update: Alendronate for Osteonecrosis in Adults With Sickle Cell Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating alendronate for treating osteonecrosis in adults with sickle cell disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteonecrosis
• Sickle Cell Disease

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: University of California, Davis | Conditions: Sickle Cell Disease, Sickle Cell Anemia | Phase 2 | Status: RECRUITING